JP2025183283A5 - - Google Patents
Info
- Publication number
- JP2025183283A5 JP2025183283A5 JP2025146941A JP2025146941A JP2025183283A5 JP 2025183283 A5 JP2025183283 A5 JP 2025183283A5 JP 2025146941 A JP2025146941 A JP 2025146941A JP 2025146941 A JP2025146941 A JP 2025146941A JP 2025183283 A5 JP2025183283 A5 JP 2025183283A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dihydroquinoline
- quinoline
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305520P | 2022-02-01 | 2022-02-01 | |
| US63/305,520 | 2022-02-01 | ||
| US202263409060P | 2022-09-22 | 2022-09-22 | |
| US63/409,060 | 2022-09-22 | ||
| JP2023013779A JP7387926B2 (ja) | 2022-02-01 | 2023-02-01 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
| JP2023138310A JP7805336B2 (ja) | 2022-02-01 | 2023-08-28 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023138310A Division JP7805336B2 (ja) | 2022-02-01 | 2023-08-28 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025183283A JP2025183283A (ja) | 2025-12-16 |
| JP2025183283A5 true JP2025183283A5 (https=) | 2026-02-10 |
Family
ID=85382684
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023013779A Active JP7387926B2 (ja) | 2022-02-01 | 2023-02-01 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
| JP2023138310A Active JP7805336B2 (ja) | 2022-02-01 | 2023-08-28 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
| JP2025146941A Pending JP2025183283A (ja) | 2022-02-01 | 2025-09-04 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023013779A Active JP7387926B2 (ja) | 2022-02-01 | 2023-02-01 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
| JP2023138310A Active JP7805336B2 (ja) | 2022-02-01 | 2023-08-28 | 選択的エストロゲン受容体分解剤の調製のためのプロセス |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11926634B2 (https=) |
| EP (1) | EP4472982A1 (https=) |
| JP (3) | JP7387926B2 (https=) |
| KR (2) | KR20250006312A (https=) |
| AU (2) | AU2023216654B2 (https=) |
| CA (1) | CA3243621A1 (https=) |
| CO (1) | CO2024009411A2 (https=) |
| CR (1) | CR20240283A (https=) |
| DO (1) | DOP2024000150A (https=) |
| IL (1) | IL313886A (https=) |
| JO (1) | JOP20240169A1 (https=) |
| MX (1) | MX2024009453A (https=) |
| PE (1) | PE20241731A1 (https=) |
| TW (2) | TW202523669A (https=) |
| WO (1) | WO2023150056A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020137965A (ja) * | 2019-03-01 | 2020-09-03 | 株式会社三洋物産 | 遊技機 |
| US20240199629A1 (en) * | 2022-02-01 | 2024-06-20 | Eli Lilly And Company | Processes for the preparation of selective estrogen receptor degraders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100849559B1 (ko) | 2004-01-22 | 2008-07-31 | 일라이 릴리 앤드 캄파니 | 혈관운동 증상의 치료를 위한 선택적 에스트로겐 수용체조절제 |
| US20080221163A1 (en) | 2005-01-18 | 2008-09-11 | Jeffrey Alan Dodge | Selective Estrogen Receptor Modulators |
| EP2343287A1 (en) | 2009-12-10 | 2011-07-13 | Almirall, S.A. | New 2-aminothiadiazole derivatives |
| AU2012257802A1 (en) | 2011-05-17 | 2013-10-31 | F. Hoffmann-La Roche Ag | Inhibitors of Bruton's tyrosine kinase |
| CA2915534A1 (en) | 2013-06-19 | 2014-12-24 | Seragon Pharmaceuticals, Inc. | Azetidine estrogen receptor modulators and uses thereof |
| WO2016097071A1 (en) | 2014-12-18 | 2016-06-23 | F. Hoffmann-La Roche Ag | Estrogen receptor modulators and uses thereof |
| CN112424205B (zh) | 2018-07-12 | 2023-10-31 | 伊莱利利公司 | 选择性的雌激素受体降解剂 |
| TWI702219B (zh) | 2018-07-12 | 2020-08-21 | 美商美國禮來大藥廠 | 選擇性雌激素受體降解劑 |
| KR20220046586A (ko) | 2019-07-22 | 2022-04-14 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 선택적 에스트로겐 수용체 분해제 |
| CA3169679A1 (en) | 2020-03-06 | 2021-09-10 | Olema Pharmaceuticals, Inc. | Methods of treating estrogen receptor-associated diseases |
| WO2021191378A1 (en) * | 2020-03-26 | 2021-09-30 | Astrazeneca Ab | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer |
| AR123185A1 (es) * | 2020-08-10 | 2022-11-09 | Novartis Ag | Compuestos y composiciones para inhibir ezh2 |
| TWI837605B (zh) | 2021-03-09 | 2024-04-01 | 美商美國禮來大藥廠 | 使用serd組合給藥方案治療癌症之方法 |
| TWI894443B (zh) | 2021-03-16 | 2025-08-21 | 美商美國禮來大藥廠 | 選擇性雌激素受體降解劑 |
-
2023
- 2023-01-27 CA CA3243621A patent/CA3243621A1/en active Pending
- 2023-01-27 CR CR20240283A patent/CR20240283A/es unknown
- 2023-01-27 KR KR1020247041076A patent/KR20250006312A/ko active Pending
- 2023-01-27 WO PCT/US2023/011671 patent/WO2023150056A1/en not_active Ceased
- 2023-01-27 PE PE2024001567A patent/PE20241731A1/es unknown
- 2023-01-27 IL IL313886A patent/IL313886A/en unknown
- 2023-01-27 AU AU2023216654A patent/AU2023216654B2/en active Active
- 2023-01-27 EP EP23707540.3A patent/EP4472982A1/en active Pending
- 2023-01-27 KR KR1020247028876A patent/KR102743629B1/ko active Active
- 2023-01-27 US US18/160,457 patent/US11926634B2/en active Active
- 2023-01-27 MX MX2024009453A patent/MX2024009453A/es unknown
- 2023-02-01 JP JP2023013779A patent/JP7387926B2/ja active Active
- 2023-02-01 TW TW113140271A patent/TW202523669A/zh unknown
- 2023-02-01 TW TW112103450A patent/TWI863110B/zh active
- 2023-08-28 JP JP2023138310A patent/JP7805336B2/ja active Active
-
2024
- 2024-07-16 CO CONC2024/0009411A patent/CO2024009411A2/es unknown
- 2024-07-30 JO JOJO/P/2024/0169A patent/JOP20240169A1/ar unknown
- 2024-07-31 DO DO2024000150A patent/DOP2024000150A/es unknown
-
2025
- 2025-09-04 JP JP2025146941A patent/JP2025183283A/ja active Pending
- 2025-09-16 AU AU2025234145A patent/AU2025234145A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025183283A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2020169171A5 (https=) | ||
| JP2022509091A5 (https=) | ||
| JP2024538705A5 (https=) | ||
| JP2021530451A5 (https=) | ||
| JP2024512154A5 (https=) | ||
| CN113906013A (zh) | 吡啶氮氧化合物及其制备方法和用途 | |
| RU2017134551A (ru) | Новые дигидропиридоизохинолиноны и их фармацевтические композиции для лечения воспалительных расстройств | |
| JP2023002516A5 (https=) | ||
| CA2506082A1 (en) | Novel medicaments for the treatment of chronic obstructive pulmonary disease | |
| JP2023082086A5 (https=) | ||
| JP2006514012A5 (https=) | ||
| JP2013541502A5 (https=) | ||
| JP2011502174A5 (https=) | ||
| BR112022022281A2 (pt) | Misturas e composições compreendendo 5-fluoro-4-imino-3-metil- 1-tosil-3,4-dihidropirimidin-2-ona e métodos de uso das mesmas | |
| JP2017522304A5 (https=) | ||
| JP2025142197A5 (https=) | ||
| JP2010505869A5 (https=) | ||
| KR101853718B1 (ko) | 코지산 유도체 제조 방법 | |
| JP2022520410A5 (https=) | ||
| JP2022541772A5 (https=) | ||
| CZ294365B6 (cs) | Deriváty kolchicinu, způsob výroby a farmaceutický prostředek | |
| AR029399A1 (es) | Compuestos derivados del benzofurano, una composicion farmaceutica, y el uso de dichos compuestos para la manufactura de un medicamento o una sal farmaceuticamente aceptable para el tratamiento de arritmias cardiacas | |
| WO2009007895A4 (en) | A compound showing anti-inflammatory activity and antiviral activity, pharmaceutical compositions comprising the same, a process for obtaining the same and use of the same in the treatment of epidemic keratoconjunctivites and herpetic stromal keratis |